IBDEI0KR ; ; 19-NOV-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,28059,0)
 ;;=365.51^^155^1750^24
 ;;^UTILITY(U,$J,358.3,28059,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28059,1,3,0)
 ;;=3^Glaucoma,Phacolytic
 ;;^UTILITY(U,$J,358.3,28059,1,4,0)
 ;;=4^365.51
 ;;^UTILITY(U,$J,358.3,28059,2)
 ;;=Phacolytic Glaucoma^265226
 ;;^UTILITY(U,$J,358.3,28060,0)
 ;;=365.01^^155^1750^21
 ;;^UTILITY(U,$J,358.3,28060,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28060,1,3,0)
 ;;=3^Glaucoma,Open Angle Suspect
 ;;^UTILITY(U,$J,358.3,28060,1,4,0)
 ;;=4^365.01
 ;;^UTILITY(U,$J,358.3,28060,2)
 ;;=Open Angle Glaucoma Suspect^268747
 ;;^UTILITY(U,$J,358.3,28061,0)
 ;;=365.04^^155^1750^37
 ;;^UTILITY(U,$J,358.3,28061,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28061,1,3,0)
 ;;=3^Ocular Hypertension
 ;;^UTILITY(U,$J,358.3,28061,1,4,0)
 ;;=4^365.04
 ;;^UTILITY(U,$J,358.3,28061,2)
 ;;=Ocular Hypertension^85124
 ;;^UTILITY(U,$J,358.3,28062,0)
 ;;=365.03^^155^1750^44
 ;;^UTILITY(U,$J,358.3,28062,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28062,1,3,0)
 ;;=3^Steroid Responder
 ;;^UTILITY(U,$J,358.3,28062,1,4,0)
 ;;=4^365.03
 ;;^UTILITY(U,$J,358.3,28062,2)
 ;;=^268749
 ;;^UTILITY(U,$J,358.3,28063,0)
 ;;=366.11^^155^1750^41
 ;;^UTILITY(U,$J,358.3,28063,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28063,1,3,0)
 ;;=3^Pseudoexfoliation w/o Glaucoma
 ;;^UTILITY(U,$J,358.3,28063,1,4,0)
 ;;=4^366.11
 ;;^UTILITY(U,$J,358.3,28063,2)
 ;;=^265538
 ;;^UTILITY(U,$J,358.3,28064,0)
 ;;=365.02^^155^1750^1
 ;;^UTILITY(U,$J,358.3,28064,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28064,1,3,0)
 ;;=3^Anatomic Narrow Angle
 ;;^UTILITY(U,$J,358.3,28064,1,4,0)
 ;;=4^365.02
 ;;^UTILITY(U,$J,358.3,28064,2)
 ;;=Anatomic Narrow Angle^268748
 ;;^UTILITY(U,$J,358.3,28065,0)
 ;;=364.53^^155^1750^39
 ;;^UTILITY(U,$J,358.3,28065,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28065,1,3,0)
 ;;=3^Pigment Dispersion w/o Glauc
 ;;^UTILITY(U,$J,358.3,28065,1,4,0)
 ;;=4^364.53
 ;;^UTILITY(U,$J,358.3,28065,2)
 ;;=^268720
 ;;^UTILITY(U,$J,358.3,28066,0)
 ;;=364.42^^155^1750^42
 ;;^UTILITY(U,$J,358.3,28066,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28066,1,3,0)
 ;;=3^Rubeosis Iridis w/o Glaucoma
 ;;^UTILITY(U,$J,358.3,28066,1,4,0)
 ;;=4^364.42
 ;;^UTILITY(U,$J,358.3,28066,2)
 ;;=Rubeosis Iridis w/o Glaucoma^268716
 ;;^UTILITY(U,$J,358.3,28067,0)
 ;;=364.77^^155^1750^2
 ;;^UTILITY(U,$J,358.3,28067,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28067,1,3,0)
 ;;=3^Angle Recession w/o Glauc
 ;;^UTILITY(U,$J,358.3,28067,1,4,0)
 ;;=4^364.77
 ;;^UTILITY(U,$J,358.3,28067,2)
 ;;=Angle Recession w/o Glauc^268743
 ;;^UTILITY(U,$J,358.3,28068,0)
 ;;=368.40^^155^1750^45
 ;;^UTILITY(U,$J,358.3,28068,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28068,1,3,0)
 ;;=3^Visual Field Defect
 ;;^UTILITY(U,$J,358.3,28068,1,4,0)
 ;;=4^368.40
 ;;^UTILITY(U,$J,358.3,28068,2)
 ;;=Visual Field Defect^126859
 ;;^UTILITY(U,$J,358.3,28069,0)
 ;;=363.70^^155^1750^4
 ;;^UTILITY(U,$J,358.3,28069,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28069,1,3,0)
 ;;=3^Choroidal Detachment NOS
 ;;^UTILITY(U,$J,358.3,28069,1,4,0)
 ;;=4^363.70
 ;;^UTILITY(U,$J,358.3,28069,2)
 ;;=^276841
 ;;^UTILITY(U,$J,358.3,28070,0)
 ;;=365.24^^155^1750^28
 ;;^UTILITY(U,$J,358.3,28070,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28070,1,3,0)
 ;;=3^Glaucoma,Residual Angle Closure
 ;;^UTILITY(U,$J,358.3,28070,1,4,0)
 ;;=4^365.24
 ;;^UTILITY(U,$J,358.3,28070,2)
 ;;=^268758
 ;;^UTILITY(U,$J,358.3,28071,0)
 ;;=365.65^^155^1750^34
 ;;^UTILITY(U,$J,358.3,28071,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28071,1,3,0)
 ;;=3^Glaucoma,Traumatic
 ;;^UTILITY(U,$J,358.3,28071,1,4,0)
 ;;=4^365.65
 ;;^UTILITY(U,$J,358.3,28071,2)
 ;;=^268780
 ;;^UTILITY(U,$J,358.3,28072,0)
 ;;=365.89^^155^1750^23
 ;;^UTILITY(U,$J,358.3,28072,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28072,1,3,0)
 ;;=3^Glaucoma,Oth Specified
 ;;^UTILITY(U,$J,358.3,28072,1,4,0)
 ;;=4^365.89
 ;;^UTILITY(U,$J,358.3,28072,2)
 ;;=^88069
 ;;^UTILITY(U,$J,358.3,28073,0)
 ;;=365.05^^155^1750^38
 ;;^UTILITY(U,$J,358.3,28073,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28073,1,3,0)
 ;;=3^Opn Ang w/ brdrlne fnd-Hi Risk
 ;;^UTILITY(U,$J,358.3,28073,1,4,0)
 ;;=4^365.05
 ;;^UTILITY(U,$J,358.3,28073,2)
 ;;=^340511
 ;;^UTILITY(U,$J,358.3,28074,0)
 ;;=365.06^^155^1750^40
 ;;^UTILITY(U,$J,358.3,28074,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28074,1,3,0)
 ;;=3^Prim Ang Clos w/o Glauc Dmg
 ;;^UTILITY(U,$J,358.3,28074,1,4,0)
 ;;=4^365.06
 ;;^UTILITY(U,$J,358.3,28074,2)
 ;;=^340512
 ;;^UTILITY(U,$J,358.3,28075,0)
 ;;=365.70^^155^1750^31
 ;;^UTILITY(U,$J,358.3,28075,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28075,1,3,0)
 ;;=3^Glaucoma,Stage NOS
 ;;^UTILITY(U,$J,358.3,28075,1,4,0)
 ;;=4^365.70
 ;;^UTILITY(U,$J,358.3,28075,2)
 ;;=^340609
 ;;^UTILITY(U,$J,358.3,28076,0)
 ;;=365.71^^155^1750^17
 ;;^UTILITY(U,$J,358.3,28076,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28076,1,3,0)
 ;;=3^Glaucoma,Mild Stage
 ;;^UTILITY(U,$J,358.3,28076,1,4,0)
 ;;=4^365.71
 ;;^UTILITY(U,$J,358.3,28076,2)
 ;;=^340513
 ;;^UTILITY(U,$J,358.3,28077,0)
 ;;=365.72^^155^1750^18
 ;;^UTILITY(U,$J,358.3,28077,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28077,1,3,0)
 ;;=3^Glaucoma,Moderate Stage
 ;;^UTILITY(U,$J,358.3,28077,1,4,0)
 ;;=4^365.72
 ;;^UTILITY(U,$J,358.3,28077,2)
 ;;=^340514
 ;;^UTILITY(U,$J,358.3,28078,0)
 ;;=365.73^^155^1750^30
 ;;^UTILITY(U,$J,358.3,28078,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28078,1,3,0)
 ;;=3^Glaucoma,Severe Stage
 ;;^UTILITY(U,$J,358.3,28078,1,4,0)
 ;;=4^365.73
 ;;^UTILITY(U,$J,358.3,28078,2)
 ;;=^340515
 ;;^UTILITY(U,$J,358.3,28079,0)
 ;;=365.74^^155^1750^14
 ;;^UTILITY(U,$J,358.3,28079,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28079,1,3,0)
 ;;=3^Glaucoma,Indeterm Stage
 ;;^UTILITY(U,$J,358.3,28079,1,4,0)
 ;;=4^365.74
 ;;^UTILITY(U,$J,358.3,28079,2)
 ;;=^340516
 ;;^UTILITY(U,$J,358.3,28080,0)
 ;;=V19.11^^155^1750^5
 ;;^UTILITY(U,$J,358.3,28080,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28080,1,3,0)
 ;;=3^Family Hx Glaucoma
 ;;^UTILITY(U,$J,358.3,28080,1,4,0)
 ;;=4^V19.11
 ;;^UTILITY(U,$J,358.3,28080,2)
 ;;=^340617
 ;;^UTILITY(U,$J,358.3,28081,0)
 ;;=V19.19^^155^1750^6
 ;;^UTILITY(U,$J,358.3,28081,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28081,1,3,0)
 ;;=3^Family Hx Oth Spec Eye Disord
 ;;^UTILITY(U,$J,358.3,28081,1,4,0)
 ;;=4^V19.19
 ;;^UTILITY(U,$J,358.3,28081,2)
 ;;=^340618
 ;;^UTILITY(U,$J,358.3,28082,0)
 ;;=365.62^^155^1750^8
 ;;^UTILITY(U,$J,358.3,28082,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28082,1,3,0)
 ;;=3^Glauc Assoc w/ Ocular Inflamm
 ;;^UTILITY(U,$J,358.3,28082,1,4,0)
 ;;=4^365.62
 ;;^UTILITY(U,$J,358.3,28082,2)
 ;;=^268777
 ;;^UTILITY(U,$J,358.3,28083,0)
 ;;=365.00^^155^1750^33
 ;;^UTILITY(U,$J,358.3,28083,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28083,1,3,0)
 ;;=3^Glaucoma,Suspects
 ;;^UTILITY(U,$J,358.3,28083,1,4,0)
 ;;=4^365.00
 ;;^UTILITY(U,$J,358.3,28083,2)
 ;;=^97584
 ;;^UTILITY(U,$J,358.3,28084,0)
 ;;=365.60^^155^1750^10
 ;;^UTILITY(U,$J,358.3,28084,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28084,1,3,0)
 ;;=3^Glauc w/ Unspec Ocular D/O
 ;;^UTILITY(U,$J,358.3,28084,1,4,0)
 ;;=4^365.60
 ;;^UTILITY(U,$J,358.3,28084,2)
 ;;=^268775
 ;;^UTILITY(U,$J,358.3,28085,0)
 ;;=365.9^^155^1750^35
 ;;^UTILITY(U,$J,358.3,28085,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28085,1,3,0)
 ;;=3^Glaucoma,Unspec
 ;;^UTILITY(U,$J,358.3,28085,1,4,0)
 ;;=4^365.9
 ;;^UTILITY(U,$J,358.3,28085,2)
 ;;=^51160
 ;;^UTILITY(U,$J,358.3,28086,0)
 ;;=365.22^^155^1750^12
 ;;^UTILITY(U,$J,358.3,28086,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28086,1,3,0)
 ;;=3^Glaucoma,Acute Angle Closure
 ;;^UTILITY(U,$J,358.3,28086,1,4,0)
 ;;=4^365.22
 ;;^UTILITY(U,$J,358.3,28086,2)
 ;;=^268754
 ;;^UTILITY(U,$J,358.3,28087,0)
 ;;=365.59^^155^1750^7
 ;;^UTILITY(U,$J,358.3,28087,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28087,1,3,0)
 ;;=3^Glauc Assoc w/ Lens D/O
 ;;^UTILITY(U,$J,358.3,28087,1,4,0)
 ;;=4^365.59
 ;;^UTILITY(U,$J,358.3,28087,2)
 ;;=^268773
 ;;^UTILITY(U,$J,358.3,28088,0)
 ;;=365.44^^155^1750^9
 ;;^UTILITY(U,$J,358.3,28088,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28088,1,3,0)
 ;;=3^Glauc Assoc w/ Systemic Syndromes
 ;;^UTILITY(U,$J,358.3,28088,1,4,0)
 ;;=4^365.44
 ;;^UTILITY(U,$J,358.3,28088,2)
 ;;=^268769
 ;;^UTILITY(U,$J,358.3,28089,0)
 ;;=377.14^^155^1750^36
 ;;^UTILITY(U,$J,358.3,28089,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28089,1,3,0)
 ;;=3^Glaucomatous Atrophy
 ;;^UTILITY(U,$J,358.3,28089,1,4,0)
 ;;=4^377.14
 ;;^UTILITY(U,$J,358.3,28089,2)
 ;;=^269218
 ;;^UTILITY(U,$J,358.3,28090,0)
 ;;=365.14^^155^1750^15
 ;;^UTILITY(U,$J,358.3,28090,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28090,1,3,0)
 ;;=3^Glaucoma,Infantile/Juv
 ;;^UTILITY(U,$J,358.3,28090,1,4,0)
 ;;=4^365.14
 ;;^UTILITY(U,$J,358.3,28090,2)
 ;;=^268750
 ;;^UTILITY(U,$J,358.3,28091,0)
 ;;=743.20^^155^1750^3
 ;;^UTILITY(U,$J,358.3,28091,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28091,1,3,0)
 ;;=3^Buphthalmous,Unsp w/ Oth Ocu Abnormal
 ;;^UTILITY(U,$J,358.3,28091,1,4,0)
 ;;=4^743.20
 ;;^UTILITY(U,$J,358.3,28091,2)
 ;;=^59682
 ;;^UTILITY(U,$J,358.3,28092,0)
 ;;=378.83^^155^1751^3
 ;;^UTILITY(U,$J,358.3,28092,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28092,1,3,0)
 ;;=3^Convergence Insufficiency
 ;;^UTILITY(U,$J,358.3,28092,1,4,0)
 ;;=4^378.83
 ;;^UTILITY(U,$J,358.3,28092,2)
 ;;=Convergence Insufficiency^269277
 ;;^UTILITY(U,$J,358.3,28093,0)
 ;;=378.00^^155^1751^5
 ;;^UTILITY(U,$J,358.3,28093,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28093,1,3,0)
 ;;=3^Esotropia
 ;;^UTILITY(U,$J,358.3,28093,1,4,0)
 ;;=4^378.00
 ;;^UTILITY(U,$J,358.3,28093,2)
 ;;=Esotropia^42597
 ;;^UTILITY(U,$J,358.3,28094,0)
 ;;=378.10^^155^1751^9
 ;;^UTILITY(U,$J,358.3,28094,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28094,1,3,0)
 ;;=3^Exotropia
 ;;^UTILITY(U,$J,358.3,28094,1,4,0)
 ;;=4^378.10
 ;;^UTILITY(U,$J,358.3,28094,2)
 ;;=Exotropia^43741
 ;;^UTILITY(U,$J,358.3,28095,0)
 ;;=378.41^^155^1751^4
